TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biototal Norden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
14,216
|
12,483
|
11,485 |
| Financial expenses |
62
|
48
|
38 |
| Earnings before taxes |
2,351
|
2,168
|
1,865 |
| EBITDA |
2,449
|
2,229
|
1,956 |
| Total assets |
6,533
|
7,872
|
5,656 |
| Current assets |
4,405
|
5,680
|
4,831 |
| Current liabilities |
6,168
|
7,499
|
5,311 |
| Equity capital |
344
|
356
|
336 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
38
|
24
|
21 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
5.3%
|
4.5%
|
5.9% |
| Turnover per employee |
374
|
520
|
547 |
| Profit as a percentage of turnover |
16.5%
|
17.4%
|
16.2% |
| Return on assets (ROA) |
36.9%
|
28.2%
|
33.6% |
| Current ratio |
71.4%
|
75.7%
|
91.0% |
| Return on equity (ROE) |
683.4%
|
609.0%
|
555.1% |
| Change turnover |
2,157
|
964
|
3,285 |
| Change turnover % |
18%
|
8%
|
40% |
| Chg. No. of employees |
14
|
3
|
4 |
| Chg. No. of employees % |
58%
|
14%
|
24% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.